Table 2.
Intervention/Model | Diabetes Model | ROS/Oxidative Stress | Cardiac Structure/Function | Author |
---|---|---|---|---|
MAO inhibitor, Clorgyline [100] or Pargyline [101] | STZ-induced T1D rats | ↓ MDA, 4-HNE ↓ MAO-A activity; ↔ MAO-A protein ↓ SOD activity; UCP3 protein; ↑ GSH-Px activity; PRX-3 protein; ↔ CAT activity; PRX-5 protein |
↓ contractile dysfunction, diastolic stiffness, electrical abnormalities ↓ morphological changes, fibrosis, apoptosis ↓ mitochondrial depolarization |
Umbarkar [100], Deshwal [101] |
CM-specific CAPN4 KO or calpastatin-TG | STZ-induced or OVE26 T1D mice | ↓ ROS, H2O2; ↔ TAC ↓ NOX, calpain activity |
↓ systolic and diastolic dysfunction ↓ cell death ↓ CM hypertrophy ↓ fibrosis, apoptosis |
Li [106], Li [107], Ni [109] |
NOX inhibitor, Apocynin | STZ-induced T1D mice | ↓ O2•− , production, NT, NO ↔ p-eNOS (Ser1177) |
↑ systolic function ↔ cardiac remodeling ↑ CM contractility |
Roe [122] |
NOX4 ASOs | STZ-induced T1D rats | ↓ NOX4; ↔ NOX1, NOX2 protein ↓ ROS (DHE), NOX-dependent O2•− production |
↓ systolic dysfunction ↓ cardiac fibrosis |
Maalouf [125] |
CM-specific RAC1 KO or NOX inhibitor, Apocynin | STZ-induced T1D mice | ↓ O2•− , H2O2 production, total/mitochondrial ROS production ↓ Rac1 mRNA/protein/activity; membrane Rac1, p67phox protein; NOX activity; Rac1, gp91phox, p67phox, p47phox mRNA ↑ TRXR activity |
↓ cardiac dysfunction ↓ CM hypertrophy ↓ cardiac fibrosis, apoptosis |
Li [124], Shen [121] |
XO inhibitor, Allopurinol | STZ-induced T1D mice/rats | ↓ ROS, 3-NT, 15-f2t-isoprostane ↓ SOD activity; MnSOD, iNOS protein, XO protein/activity; ↔ eNOS protein ↔ p22phox, p40phox, p47phox and gp91phox mRNA expression ↑ NRF2 mRNA/nuclear protein; ↓ Keap1 protein/mRNA |
↓ systolic & diastolic dysfunction ↓ cardiac remodeling & hypertrophy ↓ atrial CM disorder ↓ atrial & LV fibrosis, apoptosis |
Yang [128], Rajesh [130], Gao [131], Luo [132] |
eNOS, iNOS and nNOS KO or BH4 precursor, Sepiapterin | STZ- induced T1D mice | iNOS−/−: ↓ MDA, 4-HNE, NT protein ↓ NOx bioavailability sepiapterin: ↓ MDA, 4-HNE, NT protein ↑ BH4 and the BH4/BH2 ratio ↓ NOx bioavailability |
sepiapterin: ↑ systolic function ↓ cardiac remodeling |
Jo [144] |